NAD+observational2010

Isoform-specific targeting and interaction domains in human nicotinamide mononucleotide adenylyltransferases.

The Journal of biological chemistry

confidence

Key findings

Biochemical study on isoform-specific targeting and palmitoylation domains in human NMNATs; no clinical or biological endpoints reported.

View source on PubMed (PMID 20388704) ↗

Sample size
Not reported
Population
In vitro human nicotinamide mononucleotide adenylyltransferase isoforms (NMNAT1, NMNAT2, NMNAT3)
Dosing
Not reported
Duration
Not reported
Route
Not reported
Blinding
not_reported
Controls
not_reported
Drug class
coenzyme
Full abstract

Several important signaling pathways require NAD as substrate, thereby leading to significant consumption of the molecule. Because NAD is also an essential redox carrier, its continuous resynthesis is vital. In higher eukaryotes, maintenance of compartmentalized NAD pools is critical, but so far rather little is known about the regulation and subcellular distribution of NAD biosynthetic enzymes. The key step in NAD biosynthesis is the formation of the dinucleotide by nicotinamide/nicotinic acid mononucleotide adenylyltransferases (NMNATs). The three human isoforms were localized to the nucleus, the Golgi complex, and mitochondria. Here, we show that their genes contain unique exons that encode isoform-specific domains to mediate subcellular targeting and post-translational modifications. These domains are dispensable for catalytic activity, consistent with their absence from NMNATs of lower organisms. We further demonstrate that the Golgi-associated NMNAT is palmitoylated at two adjacent cysteine residues of its isoform-specific domain and thereby anchored at the cytoplasmic surface, a potential mechanism to regulate the cytosolic NAD pool. Insertion of unique domains thus provides a yet unrecognized enzyme targeting mode, which has also been adapted to modulate subcellular NAD supply.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.